ZHENJIANG, China, Dec. 7, 2021 /PRNewswire/ -- On December 7th, the "Opening Ceremony of GenScript ProBio Plasmid Commercial GMP Manufacturing facility and Open Day" was rounded off. GenScript ProBio ...
PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a ...
NANJING, China--(BUSINESS WIRE)--GenScript ProBio announced today the opening of China's largest commercial GMP plasmid manufacturing facility during a ceremony at the site in Zhenjiang, Jiangsu ...
The rapid advancement of cell and ex vivo gene therapies demands scalable, efficient, and regulatory-compliant manufacturing solutions. As manufacturing complexities grow, ensuring consistency, ...
The value of plasmid DNA in today’s biopharma industry cannot be overstated. Plasmid ubiquity can be seen in many therapeutic areas as they are widely used in cell and gene therapy, serve as raw ...
New York, USA, May 04, 2026 (GLOBE NEWSWIRE)-- Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight The plasmid DNA manufacturing ...
SINGAPORE, March 30, 2022 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) receives the "Best Contract Development and Manufacturing Organization Award" on the Asia ...
GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development and commercialization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results